Benztropine Psychosis

Ananth J. V. , Horodesky S. , Lehmann H. E. and Ban T. A. : Effect of withdrawal of anti-Parkinsonian medication on chronically hospitalized psychiatric patients. Laval Med. 41: 934-938, 1970

Ananth J. V. : Exacerbation of psychopathology during treatment. (In press).

Doshay L. J. , Constable K. and Fromer S. : Preliminary study of a new anti-Parkinson agent. Neurology 2: 233-243, 1952.

Doshay L. J. : Current concepts in therapy, treatment of Parkinson's disease, medicinal therapy. New Engl. J. Med. 264: 1097, 1961.

Dunlap J. C. , Miller W. C. : Toxic psychosis following the use of benztropine methane sulfonate (Cogentin). J. South Carolina Med. Ass. 65: 203-240, 1969.

Jacobziner H. and Raybin H. W. : Briefs on accidental chemical poisoning in New York City. New York State J. Med. 61: 2322-2325, 1961.

Kinross-Wright V. J. : New horizons in the chemotherapy of mental disease. South African Med. J. 31: 1167, 1957.

Leckman J. , Ananth J. V. , Ban T. A. and Lehmann H. E. : Adverse reactions: Predisposing factors. To be published.

Pecknold J. C. , Ananth J. V. , Ban T. A. and Lehmann H. E. : Lack of indication for use of anti-Parkinson medication. Dis-Nerv. Syst. 52(8): 538-541, 1971.

Pfeiffer C. C. , Murphee H. B. , Jenney E. H. , Robertson M. B. , Randall A. H. and Bryan L. : Hallucinatory effect in man of acetyl choline inhibitors. Neurology 9: 249-250, 1959.

Sigwald J. : Etude de l'action de la Benztropine sur le syndrome extrapyramidal (study of the effect of benztropine on the extrapyramidal syndrome). Presse Med. 72: 93-94, 1964.

Strang R. R. : Experiences with Cogentin in the treatment of Parkinsonism. Acta Neurologia Scand. 41: 413-418, 1965.

Warnes H. : Toxic psychosis due to antiparkinsonian drugs. Can, Psychiatr. Assoc. J. 12: 323-326, 1967.